Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 1
1990 3
1992 1
1995 6
1996 2
1997 4
1998 4
1999 7
2000 3
2001 5
2002 5
2003 5
2004 9
2005 8
2006 4
2007 12
2008 5
2009 9
2010 7
2011 16
2012 20
2013 10
2014 13
2015 11
2016 12
2017 15
2018 6
2019 10
2020 16
2021 23
2022 14
2023 14
2024 9
2025 9
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators. Bachelez H, et al. N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563. N Engl J Med. 2021. PMID: 34936739 Free article. Clinical Trial.
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE, van de Kerkhof P, Gudjonsson JE, de la Cruz C, Barker J, Morita A, Romiti R, Affandi AM, Asawanonda P, Burden AD, Gonzalez C, Marrakchi S, Mowla MR, Okubo Y, Oon HH, Terui T, Tsai TF, Callis-Duffin K, Fujita H, Jo SJ, Merola J, Mrowietz U, Puig L, Thaçi D, Velásquez M, Augustin M, El Sayed M, Navarini AA, Pink A, Prinz J, Turki H, Magalhães R, Capon F, Bachelez H; IPC Pustular Psoriasis Working Group. Choon SE, et al. Among authors: bachelez h. JAMA Dermatol. 2024 Jul 1;160(7):758-768. doi: 10.1001/jamadermatol.2024.0915. JAMA Dermatol. 2024. PMID: 38691347
Reply.
Assan F, Bachelez H. Assan F, et al. Among authors: bachelez h. J Allergy Clin Immunol. 2020 Aug;146(2):461-462. doi: 10.1016/j.jaci.2020.04.016. Epub 2020 May 29. J Allergy Clin Immunol. 2020. PMID: 32482528 No abstract available.
Reply.
Bachelez H, Assan F. Bachelez H, et al. J Allergy Clin Immunol. 2020 Aug;146(2):458-459. doi: 10.1016/j.jaci.2020.03.024. Epub 2020 Apr 30. J Allergy Clin Immunol. 2020. PMID: 32362532 No abstract available.
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Gordon KB, Strober B, Lebwohl M, Augustin M, Blauvelt A, Poulin Y, Papp KA, Sofen H, Puig L, Foley P, Ohtsuki M, Flack M, Geng Z, Gu Y, Valdes JM, Thompson EHZ, Bachelez H. Gordon KB, et al. Among authors: bachelez h. Lancet. 2018 Aug 25;392(10148):650-661. doi: 10.1016/S0140-6736(18)31713-6. Epub 2018 Aug 7. Lancet. 2018. PMID: 30097359 Clinical Trial.
Éditorial.
Viguier M, Aubin F, Bachelez H, Beylot-Barry M, Richard MA; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Viguier M, et al. Among authors: bachelez h. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):423-425. doi: 10.1016/j.annder.2019.04.018. Epub 2019 Jun 20. Ann Dermatol Venereol. 2019. PMID: 31229352 French. No abstract available.
Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment.
Abboud E, Chrayteh D, Boussetta N, Dalle H, Malerba M, Wu TD, Le Gall M, Reelfs O, Pourzand C, Mellett M, Assan F, Bachelez H, Poupon J, Aractingi S, Vaulont S, Sohier P, Oules B, Karim Z, Peyssonnaux C. Abboud E, et al. Among authors: bachelez h. Nat Commun. 2024 Aug 7;15(1):6718. doi: 10.1038/s41467-024-50993-8. Nat Commun. 2024. PMID: 39112467 Free PMC article.
[Infliximab].
Goujon C, Bachelez H; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Goujon C, et al. Among authors: bachelez h. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):483-486. doi: 10.1016/j.annder.2019.04.013. Epub 2019 Jun 20. Ann Dermatol Venereol. 2019. PMID: 31230775 French. No abstract available.
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).
Strober B, Bachelez H, Crowley J, Elewski BE, Gooderham M, Menter A, Strohal R, Chen MM, Wu T, Zhan T, Photowala H, Armstrong A. Strober B, et al. Among authors: bachelez h. J Eur Acad Dermatol Venereol. 2024 May;38(5):864-872. doi: 10.1111/jdv.19748. Epub 2024 Jan 5. J Eur Acad Dermatol Venereol. 2024. PMID: 38179809 Clinical Trial.
[Pustular psoriasis].
Bachelez H. Bachelez H. Ann Dermatol Venereol. 2012 Apr;139 Suppl 2:S34-8. doi: 10.1016/S0151-9638(12)70108-4. Ann Dermatol Venereol. 2012. PMID: 22541726 French.
268 results